- Home
- LUNR vs LXRX Comparison
LUNR vs LXRX Comparison
Compare LUNR & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNR
- LXRX
- Stock Information
- Founded
- LUNR 2013
- LXRX 1995
- Country
- LUNR United States
- LXRX United States
- Employees
- LUNR N/A
- LXRX N/A
- Industry
- LUNR Industrial Machinery/Components
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- LUNR Industrials
- LXRX Health Care
- Exchange
- LUNR Nasdaq
- LXRX Nasdaq
- Market Cap
- LUNR 741.2M
- LXRX 650.7M
- IPO Year
- LUNR N/A
- LXRX 2000
- Fundamental
- Price
- LUNR $12.42
- LXRX $0.98
- Analyst Decision
- LUNR Strong Buy
- LXRX Buy
- Analyst Count
- LUNR 5
- LXRX 2
- Target Price
- LUNR $13.10
- LXRX $6.00
- AVG Volume (30 Days)
- LUNR 17.1M
- LXRX 4.3M
- Earning Date
- LUNR 11-14-2024
- LXRX 11-12-2024
- Dividend Yield
- LUNR N/A
- LXRX N/A
- EPS Growth
- LUNR N/A
- LXRX N/A
- EPS
- LUNR N/A
- LXRX N/A
- Revenue
- LUNR $203,899,000.00
- LXRX $5,229,000.00
- Revenue This Year
- LUNR $185.92
- LXRX $1,212.46
- Revenue Next Year
- LUNR $66.25
- LXRX $219.10
- P/E Ratio
- LUNR N/A
- LXRX N/A
- Revenue Growth
- LUNR 134.51
- LXRX 886.60
- 52 Week Low
- LUNR $2.09
- LXRX $0.97
- 52 Week High
- LUNR $14.90
- LXRX $3.73
- Technical
- Relative Strength Index (RSI)
- LUNR 68.89
- LXRX 25.78
- Support Level
- LUNR $7.55
- LXRX $1.01
- Resistance Level
- LUNR $14.90
- LXRX $1.35
- Average True Range (ATR)
- LUNR 1.26
- LXRX 0.12
- MACD
- LUNR 0.34
- LXRX -0.06
- Stochastic Oscillator
- LUNR 66.89
- LXRX 0.43
About LUNR Intuitive Machines Inc.
Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.